1
|
Häussler B, Schmalfeldt B, Häussler S, Köninger A, Loos S, Naumann G, Scharl A, Thaler CJ, Weiss M, Albrecht M. National and International Comparisons of Gynecological Research in Germany Based on a Bibliometric Analysis of Publications. Geburtshilfe Frauenheilkd 2024; 84:346-356. [PMID: 38618578 PMCID: PMC11006559 DOI: 10.1055/a-2200-4122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Accepted: 02/08/2024] [Indexed: 04/16/2024] Open
Abstract
Background Recent years have seen a considerable shift from male doctors to female doctors in the field of gynecology. Female doctors are traditionally more involved with planning and maintaining their family. For gynecology, this could be associated with a risk that research activities will decrease, particularly if results are published in scientific journals. Methods In view of this shift, a comparative observational study was carried for 2022 in which 1306 publications were matched to 1786 female and male doctors reported on the websites of the 44 locations of university gynecology departments in Germany. In addition, the volume of publications issued between 2014 and 2022 was compared for Germany, France, the United Kingdom, and the United States. In Germany, the volume of publications in Gynecology was additionally compared with the publication outputs of the specialties Urology and Trauma Surgery. Results Since 2014, the increase in the numbers of publications in the field of Gynecology in Germany was lower (225%) than that of the countries with which it was compared (238%/252%/260% for F/UK/USA). When Gynecology was compared with other medical specialties in Germany, the number of publications in Urology were found to have increased at a lower rate (196%) while the number of publications in the field of Trauma Surgery increased by more (286%) than that of Gynecology. At the start of 2023, the percentage of women who were working as doctors at the lowest hierarchical level (junior doctor) was 81%. The publication output per capita of female doctors working at lower levels in the medical hierarchy, i.e., working as junior doctors and senior physicians, was between 40% and 80% lower than that of male doctors working at the same level. However, female directors published as much as male directors did. In the lower hierarchy levels, men were up to 14% more likely to be without an academic title. Predictors for more extensive publication activities by young female and male doctors include the extent and quality of publications by doctors in senior positions, the presence of a comprehensive cancer center or an institute for human genetics at the location where the young doctors were working, and joint publications with foreign authors. Conclusion For the German Society of Gynecology and Obstetrics, the results suggest a number of approaches to promote young researchers. The support provided to young female doctors is especially important as this should help to retain them as junior researchers over the long term.
Collapse
Affiliation(s)
| | | | | | - Angela Köninger
- Gynecology and Obstetrics, University Regensburg, Regensburg, Germany
| | | | - Gert Naumann
- Gynecology and Obstetrics, HELIOS Klinikum Erfurt, Erfurt, Germany
| | - Anton Scharl
- Onkologische Fachklinik Bad Trissl, Oberaudorf, Germany
| | - Christian J. Thaler
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, Hormon- & Kinderwunschzentrum Großhadern, München, Germany
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, Hormon- & Kinderwunschzentrum Innenstadt, München, Germany
| | - Martin Weiss
- Universitäts-Frauenklinik, Eberhard-Karls-Universität Tübingen Medizinische Fakultät, Tübingen, Germany
| | | |
Collapse
|
2
|
Batz F, Lermer E, Lech S, O'Malley G, Zati Zehni A, Zenz-Spitzweg D, Mahner S, Behr J, J Thaler C, Buspavanich P. Publisher Correction: The psychological burden of COVID-19 on the desire for parenthood in minoritized sexual identities: a study on depressive symptoms and family planning in Germany. BMC Public Health 2023; 23:609. [PMID: 36997987 DOI: 10.1186/s12889-023-15385-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/01/2023] Open
Affiliation(s)
- Falk Batz
- Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Eva Lermer
- Center for Leadership and People Management, LMU Munich, Munich, Germany
- Department of Business Psychology, Augsburg University of Applied Sciences, Augsburg, Germany
| | - Sonia Lech
- Institute of Medical Sociology and Rehabilitation Science, Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany
| | - Grace O'Malley
- Department of Paediatric Oncology/Haematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Alaleh Zati Zehni
- Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Davina Zenz-Spitzweg
- Applied Business and Media Psychology, Ansbach University of Applied Sciences, Ansbach, Germany
| | - Sven Mahner
- Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Joachim Behr
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Fehrbelliner Str. 38, 16816, Neuruppin, Germany
- Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany
- Research Unit Gender in Medicine, Department of Psychiatry and Psychotherapy, Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian J Thaler
- Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Pichit Buspavanich
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Fehrbelliner Str. 38, 16816, Neuruppin, Germany.
- Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany.
- Research Unit Gender in Medicine, Department of Psychiatry and Psychotherapy, Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
| |
Collapse
|
3
|
Birkhäuser M, Böttcher B, Germeyer A, Hadji P, Imthurn B, Mueck AO, Neulen J, Stute P, Thaler CJ, Wiegratz I, Wildt L. The risk of thromboembolism and use of combined oral contraceptives: a comment. BJOG 2023; 130:844-845. [PMID: 36890428 DOI: 10.1111/1471-0528.17434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Accepted: 01/03/2023] [Indexed: 03/10/2023]
Affiliation(s)
- Martin Birkhäuser
- Department of Gynecologic Endocrinology and Reproductive Medicine, University Women's Hospital, Bern, Switzerland
| | - Bettina Böttcher
- Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck, Austria
| | - Ariane Germeyer
- Department of Gynecological Endocrinology and Fertility Disorders, University Hospital Heidelberg, Heidelberg, Germany
| | - Peyman Hadji
- Frankfurt Center of Bone Health and Endocrinology & Philipps University of Marburg, Marburg, Germany
| | | | - Alfred O Mueck
- University Hospitals of Tuebingen, Tuebingen, Germany.,Capital Medical University Beijing, Beijing, China
| | - Joseph Neulen
- Department of Geriatric Medicine, RWTH Aachen, University of Aachen, Aachen, Germany
| | - Petra Stute
- Department of Obstetrics and Gynecology, University Clinic Inselspital Bern, Bern, Switzerland
| | - Christian J Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital, LMU, Munich, Germany
| | - Inka Wiegratz
- Frankfurt Center of Fertility and Hormones & Goethe University Frankfurt, Frankfurt, Germany
| | - Ludwig Wildt
- Medical University of Innsbruck, Innsbruck, Austria
| |
Collapse
|
4
|
Batz F, Lermer E, Lech S, O’Malley G, Zati zehni A, Zenz-Spitzweg D, Mahner S, Behr J, Thaler CJ, Buspavanich P. The psychological burden of COVID-19 on the desire for parenthood in minoritized sexual identities: a study on depressive symptoms and family planning in Germany. BMC Public Health 2023; 23:232. [PMID: 36732703 PMCID: PMC9894671 DOI: 10.1186/s12889-023-15127-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 01/21/2023] [Accepted: 01/24/2023] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND The COVID-19 pandemic continues to spread across the globe and is associated with significant clinical and humanitarian burden. The desire for parenthood has been described to be positively correlated with psychological well-being: An unfulfilled wish for parenthood is associated with impaired mental health, and the wish for parenthood is a predictor for the development of depressive symptoms. While higher rates of anxiety and depression have been reported in individuals with minoritized sexual identities (compared to heterosexual individuals) during the COVID-19 pandemic, the specific impact of the pandemic and its social restriction measures on this population is poorly understood. METHODS From April to July 2020, we conducted an anonymous cross-sectional survey online among N = 2463 adults living in Germany. We screened for depressive symptoms (Patient Health Questionnaire-4; PHQ-4) and assessed individuals' desire for parenthood during the pandemic, and motives for or against the desire for parenthood (Leipzig questionnaire on motives for having a child, Version 20; LKM-20), with the aim of identifying differences between individuals with minoritized sexual identities and heterosexual individuals. RESULTS Compared to heterosexual individuals (n = 1304), individuals with minoritized sexual identities (n = 831) indicated higher levels of depressive symptoms. In our study sample the majority of all participants (81.9%) reported no change in the desire for parenthood since the COVID-19 pandemic. CONCLUSION The findings underline the unmet need for social, psychological and medical support in regard to family-planning and the desire for parenthood during a pandemic. Furthermore, future research should explore COVID-19-related psychological consequences on individuals' desire for parenthood and building a family.
Collapse
Affiliation(s)
- Falk Batz
- grid.411095.80000 0004 0477 2585Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Eva Lermer
- grid.5252.00000 0004 1936 973XCenter for Leadership and People Management, LMU Munich, Munich, Germany ,grid.440970.e0000 0000 9922 6093Department of Business Psychology, Augsburg University of Applied Sciences, Augsburg, Germany
| | - Sonia Lech
- grid.6363.00000 0001 2218 4662Institute of Medical Sociology and Rehabilitation Science, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany ,grid.6363.00000 0001 2218 4662Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Grace O’Malley
- grid.6363.00000 0001 2218 4662Department of Paediatric Oncology/Haematology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Alaleh Zati zehni
- grid.411095.80000 0004 0477 2585Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Davina Zenz-Spitzweg
- grid.448997.f0000 0000 8984 4939 Applied Business and Media Psychology, Ansbach University of Applied Sciences, Ansbach, Germany
| | - Sven Mahner
- grid.411095.80000 0004 0477 2585Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Joachim Behr
- grid.473452.3Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Fehrbelliner Str. 38, 16816 Neuruppin, Germany ,Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany ,grid.6363.00000 0001 2218 4662Research Unit Gender in Medicine, Department of Psychiatry and Psychotherapy, Institute of Sexology and Sexual Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian J. Thaler
- grid.411095.80000 0004 0477 2585Department of Obstetrics and Gynecology, Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Pichit Buspavanich
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Fehrbelliner Str. 38, 16816, Neuruppin, Germany. .,Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany. .,Research Unit Gender in Medicine, Department of Psychiatry and Psychotherapy, Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
| |
Collapse
|
5
|
Pavlik R, Hecht S, Noss U, Soldin OP, Mendu RD, Soldin SJ, Lohse P, Thaler CJ. Reduced Steroid Synthesis in the Follicular Fluid of MTHFR 677TT Mutation Carriers: Effects of Increased Folic Acid Administration. Geburtshilfe Frauenheilkd 2022; 82:1074-1081. [PMID: 36186148 PMCID: PMC9525144 DOI: 10.1055/a-1791-9358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Accepted: 07/24/2022] [Indexed: 10/27/2022] Open
Abstract
Objective To compare steroid profiles in the follicular fluid (FF) from women homozygous for the methylenetetrahydrofolate reductase (MTHFR) 677C>T mutation and wildtype controls and to correlate it with the folic acid administration scheme applied at the time of oocyte retrieval. Design Retrospective single center study. Subjects and Methods Infertile patients treated by using assisted reproductive techniques were genotyped routinely for the MTHFR 677C>T mutation. In 2006 they had received folic acid supplementation doses of 400 µg daily per os. This group was designated Group-400 (n = 10). From 2008 onwards, all of our infertility patients received a daily dose of 800 µg folic acid per os. Women from this group were designated Group-800 (n = 28). FF were collected and a panel of steroid hormones (estradiol, estrone, estriol, cortisol, progesterone, 17-OH progesterone, testosterone, androstenedione, aldosterone, DHEA, and DHEA-S) was measured by isotope dilution liquid chromatography-tandem mass spectrometry employing atmospheric pressure photo ionization (APPI). Results In Group-400, the FF hormone profile confirmed a significant reduction of estradiol in homozygous 677TT carriers (0.52 ± 0.08-fold, exact p = 0.032) and for the first time also revealed significantly reduced estriol concentrations in these individuals (0.54 ± 0.05-fold, p = 0.016), as compared to wildtype controls. In Group-800, no significant differences were found for concentrations of any of the steroid hormones between homozygous 677TT carriers and wildtype controls. Conclusions The current findings support and extend previous reports on reduced concentrations of specific steroid hormones in follicular fluids of homozygous MTHFR 677C>T mutation carriers. The restoration of the FF hormone profile by elevated-dose folic acid supplementation might impact performing ART in infertile women with the MTHFR 677TT-genotype. Further adequately powered studies are necessary to verify our finding and to demonstrate the clinical effect of enhanced folic supplementation on ovarian function.
Collapse
Affiliation(s)
- Roman Pavlik
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, Ludwig-Maximilians University, Munich,
Germany,TFP Fertility Wels, Wels, Austria
| | - Stephanie Hecht
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, Ludwig-Maximilians University, Munich,
Germany,Practice for Obstetrics and Gynecology, Erfurt, Germany
| | - Ulrich Noss
- Centre for Reproductive Medicine, Munich, Germany
| | - Offie P. Soldin
- Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, D.C., USA
| | - Rao D. Mendu
- Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, D.C., USA
| | - Steven J. Soldin
- Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, D.C., USA
| | - Peter Lohse
- Department of Clinical Chemistry, University Hospital, Ludwig-Maximilians University, Munich, Germany
| | - Christian J. Thaler
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, Ludwig-Maximilians University, Munich,
Germany,Korrespondenzadresse Univ.-Prof. Dr. med. Christian J. Thaler, M.I.A.C., F.C.R.I. University Hospital, Ludwig-Maximilians University, Department of Obstetrics and
Gynecology and Center for Gynecological Endocrinology and Reproductive MedicineMarchioninistraße 1581377
MunichGermany
| |
Collapse
|
6
|
Rogenhofer N, Jeschke U, von Schönfeldt V, Mahner S, Thaler CJ. Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI. Arch Gynecol Obstet 2022; 306:219-228. [PMID: 35220479 PMCID: PMC9300486 DOI: 10.1007/s00404-022-06419-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 01/24/2022] [Indexed: 02/06/2023]
Abstract
OBJECTIVE Recent studies revealed intriguing associations between cholecalciferol (D3) and reproductive functions. Seasonal changes of D3 concentrations are well known; however, they are not always considered in the context of reproductive functions. In this study, we analyzed D3 serum concentration in IVF/ICSI patients with respect to seasonal 3-month quartiles and anti-Muellerian hormone (AMH) referring to the impact on Assisted Reproductive Technologies (ART) outcome. MATERIALS AND RESEARCH METHODS We studied 469 female patients, presenting between 2012 and 2018 for ART treatment in our fertility center. D3 as well as the AMH serum concentrations were measured at the beginning of the follicle stimulation (days 3-5 of menstrual cycles). Results were evaluated with respect to seasonal quartiles and outcome of the ART cycles. RESULTS D3 concentrations showed significant fluctuations within annual quartiles with a pronounced peak in August-October and a minimum in February-April (26.0 vs. 20.5 mg/dl; p < 0.0001). Similar seasonal dynamics were found for AMH (2.98 vs. 1.78 ng/ml; p = 0.010) and these were associated with significantly shorter stimulation periods during August-October (11.29 vs. 12.12 days; p = 0.042), higher number of fertilized oocytes between August and October (6.23 vs. 4.97; p = 0.05) along with a trend towards higher numbers of cumulus-oocyte complexes. However, no such differences were found for the numbers of MII oocytes or pregnancy rates. CONCLUSION Our data indicate seasonal 3-month quartile variations of AMH concentrations and characteristics of ART, such as days of ovarian stimulation and number of fertilized oocytes. Highest AMH concentrations were found between August and October and this quartile was associated with highest D3 concentrations.
Collapse
Affiliation(s)
- Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
| | - Udo Jeschke
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.,Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany
| | - Viktoria von Schönfeldt
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany
| | - Sven Mahner
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany
| | - Christian J Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany
| |
Collapse
|
7
|
Batz F, Lermer E, Hatzler L, Vilsmaier T, Schröder L, Chelariu-Raicu A, Behr J, Mahner S, Buspavanich P, Thaler CJ. The Impact of the COVID-19 Pandemic on Sexual Health in Cis Women Living in Germany. J Sex Med 2022; 19:907-922. [PMID: 35370105 PMCID: PMC8898699 DOI: 10.1016/j.jsxm.2022.02.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2021] [Revised: 02/12/2022] [Accepted: 02/26/2022] [Indexed: 01/25/2023]
Abstract
BACKGROUND Preliminary research shows a substantial impact of the COVID-19 pandemic on women's sexual health, whereby empirical work on sexual well-being of minoritized sexual identities is still rare. AIM The objective of this study was to explore sexual health in heterosexual, lesbian and bisexual cis women during the first wave of COVID-19 pandemic in Germany. METHODS An anonymous nationwide online survey was conducted among cis women during the first nationwide lockdown in Germany from April 20th to July 20th, 2020. The questionnaire was distributed via e-mail, online chats and social-media platforms. OUTCOMES Demographic variables and self-report measures from the Sexual Behavior Questionnaire (SBQ-G) "before the pandemic" and "since the pandemic" were collected. RESULTS A total of 1,368 cis women participants were included: heterosexual women (n = 844), lesbian women (n = 293), bisexual women (n = 231). Results indicate overall decrease in frequency of sexual contacts and masturbation during the COVID-19 pandemic. Regarding differences before and during the pandemic lesbian women showed significant changes in sexual arousal whereas heterosexual women showed significant changes in all dimensions except capability to enjoy sexual intercourse. The data of bisexual women showed significant changes in almost all dimensions except for frequency of sexual intercourse and sexual arousal. Results of the multiple regression analysis revealed that being younger than 36 years-old, and being in a relationship as well as being heterosexual (compared with being lesbian) is positively associated with general satisfaction with sexual life during the pandemic. CLINICAL IMPLICATIONS The findings suggest that during a pandemic sexual and mental health care for (cis) women should be provided and address the specific needs of sexual minority groups. STRENGTHS & LIMITATIONS This is the first study to describe sexual behavior in heterosexual, lesbian and bisexual women during the COVID-19 pandemic in Germany. Limitations, however, include the fact that the data described were obtained at only one time point so there is a possibility of recall bias, and that the results cannot be generalized because of the underrepresentation of women over age 46. CONCLUSION This study examined the impact of the COVID-19 pandemic and resulting social constraints on the sexual health of particular groups of lesbian and bisexual women, which may improve preparedness for future public health and policy crises. Batz F, Lermer E, Hatzler L, et al. The Impact of the COVID-19 Pandemic on Sexual Health in Cis Women Living in Germany. J Sex Med 2022;19:907-922.
Collapse
Affiliation(s)
- Falk Batz
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| | - Eva Lermer
- Center for Leadership and People Management, LMU Munich, Germany; Applied Business and Media Psychology - Ansbach University of Applied Sciences, Ansbach, Germany
| | - Laura Hatzler
- Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Gynecology and Breast Center, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Theresa Vilsmaier
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| | - Lennard Schröder
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| | - Anca Chelariu-Raicu
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| | - Joachim Behr
- Research Department of Experimental and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany
| | - Sven Mahner
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| | - Pichit Buspavanich
- Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany; Institute Gender in Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
| | - Christian J Thaler
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Germany
| |
Collapse
|
8
|
Rogenhofer N, Mahner S, von Hasselbach YL, Thaler CJ. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report. Am J Reprod Immunol 2021; 87:e13506. [PMID: 34935238 DOI: 10.1111/aji.13506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 10/18/2021] [Accepted: 10/26/2021] [Indexed: 11/30/2022] Open
Abstract
PROBLEM Some studies suggest intravenous intralipid infusions (IVIL) to be effective in the treatment of immune-mediated pregnancy failure. To this date it remains to be established, how IVIL might protect pregnancy and therefore a specific subgroup of RPL patients that might benefit from IVIL has not been defined. Anti-trophoblast antibodies (ATAb) have been associated with RPL and appear to mediate immune pathology. We have shown, that ATAb in vitro decrease HCG- and progesterone production pointing to a mechanism how ATAb interfere with normal pregnancies. We have measured ATAb-activities in patients undergoing off label IVIL-treatment. METHOD OF STUDY Ten RPL-patients with positive ATAb, determined by using the choriocarcinoma cellline JEG-3 and flow cytometry as described before, and otherwise unexplained RPL, received off-label IVIL during pregnancy. Two ATAb-positive RPL patients preferred expectant management. In addition, ATAb-activity was studied in pregnancies of two healthy ATAb-negative volunteers without miscarriages. RESULTS In RPL patients receiving IVIL, relative ATAb-activity decreased from an average of 56.8±17.0% to 20.8±11.0% (P < .001). The two RPL-patients without IVIL, aborted at 6+3gw and 7+4gw and embryonic genetic testing revealed euploid karyotypes. During pregnancies of the two healthy ATAb-negative individuals, ATAb-activities remained negative (16±9.8%) without significant changes (P = .22). Nine of the 10 pregnancies receiving IVIL proceeded uneventful with healthy newborns ≥37gw. One patient receiving IVIL aborted at 7+6gw and embryonic genetic-testing revealed a trisomy 16. No specific side effects concerning IVIL were noted. CONCLUSIONS Intralipid preparations during pregnancies of ATAb-positive RPL-patients significantly reduce ATAb-activities and this may indicate a therapeutic mechanism of IVIL.
Collapse
Affiliation(s)
- Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich - Großhadern, Munich, Germany
| | - Sven Mahner
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich - Großhadern, Munich, Germany
| | | | - Christian J Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, University Hospital LMU Munich - Großhadern, Munich, Germany
| |
Collapse
|
9
|
Buspavanich P, Lech S, Lermer E, Fischer M, Berger M, Vilsmaier T, Kaltofen T, Keckstein S, Mahner S, Behr J, Thaler CJ, Batz F. Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individuals. PLoS One 2021; 16:e0252356. [PMID: 34101746 PMCID: PMC8186787 DOI: 10.1371/journal.pone.0252356] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Accepted: 05/12/2021] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Preliminary empirical data indicates a substantial impact of the COVID-19 pandemic on well-being and mental health. Individuals with minoritized sexual and gender identities are at a higher risk of experiencing such negative changes in their well-being. The objective of this study was to compare levels of well-being among cis-heterosexual individuals and individuals with minoritized sexual and gender identities during the COVID-19 pandemic. METHODS Using data obtained in a cross-sectional online survey between April 20 to July 20, 2020 (N = 2332), we compared levels of well-being (WHO-5) across subgroups (cis-individuals with minoritized sexual identities, individuals with minoritized gender identities and cis-heterosexual individuals) applying univariate (two-sample t-test) and multivariate analysis (multivariate linear regression). RESULTS Results indicate overall lower levels of well-being as well as lower levels of well-being in minoritized sexual or gender identities compared to cis-heterosexual individuals. Further, multivariate analyses revealed that living in urban communities as well as being in a relationship were positively associated with higher levels of well-being. Furthermore, a moderation analysis showed that being in a relationship reduces the difference between groups in terms of well-being. CONCLUSION Access to mental healthcare for individuals with minoritized sexual and gender identities as well as access to gender-affirming resources should be strengthened during COVID-19 pandemic. Healthcare services with low barriers of access such as telehealth and online peer support groups should be made available, especially for vulnerable groups.
Collapse
Affiliation(s)
- Pichit Buspavanich
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany
- Department of Psychiatry and Psychotherapy, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Institute of Sexology and Sexual Medicine, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Sonia Lech
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany
- Department of Psychiatry and Psychotherapy, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Institute of Medical Sociology and Rehabilitation Science, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Eva Lermer
- Center for Leadership and People Management, LMU Munich, Munich, Germany
- FOM University of Applied Sciences of Economics and Management, Essen, Germany
| | - Mirjam Fischer
- Institute of Sociology and Social Psychology, University of Cologne, Cologne, Germany
| | - Maximilian Berger
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany
- Department of Psychiatry and Psychotherapy, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Theresa Vilsmaier
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Till Kaltofen
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Simon Keckstein
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Sven Mahner
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Joachim Behr
- Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany
- Research Department of Experimental and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany
| | - Christian J. Thaler
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Falk Batz
- Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany
| |
Collapse
|
10
|
Batz F, Becker J, Alba-Alejandre I, Thaler CJ, Rogenhofer N. Reproduktionsmedizinische Aspekte bei Transsexualität. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- F Batz
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - J Becker
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - I Alba-Alejandre
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - CJ Thaler
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - N Rogenhofer
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| |
Collapse
|
11
|
Batz F, Becker J, Alba-Alejandre I, Thaler CJ, Rogenhofer N. Mangelnde gynäkologische Versorgung nach geschlechtsangleichender Therapien bei Transidentität. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- F Batz
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - J Becker
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - I Alba-Alejandre
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - CJ Thaler
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| | - N Rogenhofer
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Hormon- und Kinderwunschzentrum
| |
Collapse
|
12
|
Rogenhofer N, Hulde N, Brettner F, Götzfried I, Buchheim JI, Kammerer T, Dendorfer A, Chouker A, Hofmann-Kiefer KF, Rehm M, Thaler CJ. Effects of controlled ovarian stimulation on vascular barrier and endothelial glycocalyx a pilot study. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- N Rogenhofer
- LMU Klinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum
| | - N Hulde
- LMU Klinik für Anästhesiologie
| | | | | | | | | | | | | | | | - M Rehm
- LMU Klinik für Anästhesiologie
| | - CJ Thaler
- LMU Klinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum
| |
Collapse
|
13
|
Rogenhofer N, Markoff A, Ennerst X, Bogdanova N, Thaler CJ. Maternale sowie paternale M2/Annexin-A5 Trägerschaft als Risikofaktor für rezidivierendes Implntationsversagen (RIF). Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- N Rogenhofer
- LMU Klinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum
| | - A Markoff
- Institut für medizinische Biochemie, ZMBE und IZKF (ehem.)
| | - X Ennerst
- LMU Klinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum
| | | | - CJ Thaler
- LMU Klinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum
| |
Collapse
|
14
|
Eggersmann TK, Baumeister P, Kumbrink J, Mayr D, Schmoeckel E, Thaler CJ, Dannecker C, Jeschke U, Nagler T, Mahner S, Sharaf K, Gallwas JKS. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients. Anticancer Res 2020; 40:2117-2123. [PMID: 32234904 DOI: 10.21873/anticanres.14170] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 03/09/2020] [Accepted: 03/11/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM The incidence of human papilloma virus (HPV)-related head and neck squamous cell carcinoma (HNSCC) has been increasing in the last decades. Analysis of oral brushing or rinsing samples for screening or stratification could potentially improve screening and prevention. PATIENTS AND METHODS Oral brushes and mouthwashes were taken from 20 patients with HPV-associated HNSCC before definite therapy. HPV genotyping was performed for the detection of 14 high-risk HPV subtypes and correlated to DNA isolated from tumor tissue. RESULTS Ten of 20 patients were tested HPV positive by using either method. There was a significant correlation between macroscopic visibility of tumor and positive HPV detection (p<0.001) and HPV detection and tumor size (p<0.001). HPV was detected in all macroscopically visible tumors. Half of the HPV cases who had macroscopically invisible tumors were missed by both methods. CONCLUSION Both techniques are limited in the detection of macroscopically non-visible and small tumors. Therefore, the application of these techniques for screening or diagnosis of HNSCC is not recommended.
Collapse
Affiliation(s)
- Tanja K Eggersmann
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany
| | - Philipp Baumeister
- Department of Otorhinolaryngology, University Hospital, LMU Munich, Munich, Germany
| | - Jorg Kumbrink
- Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany
| | - Doris Mayr
- Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany
| | - Elisa Schmoeckel
- Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany
| | - Christian J Thaler
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany
| | - Christian Dannecker
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.,Department for Gynecology and Obstetrics, University of Augsburg, Augsburg, Germany
| | - Udo Jeschke
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.,Department for Gynecology and Obstetrics, University of Augsburg, Augsburg, Germany
| | - Thomas Nagler
- Mathematical Institute, Leiden University, Leiden, the Netherlands
| | - Sven Mahner
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany
| | - Kariem Sharaf
- Department of Otorhinolaryngology, University Hospital, LMU Munich, Munich, Germany
| | - Julia K S Gallwas
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.,Department of Gynecology and Obstetrics, Georg-August-University Goettingen, Goettingen, Germany
| |
Collapse
|
15
|
Ye Y, Kuhn C, Kösters M, Arnold GJ, Ishikawa-Ankerhold H, Schulz C, Rogenhofer N, Thaler CJ, Mahner S, Fröhlich T, Jeschke U, von Schönfeldt V. Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages. EBioMedicine 2019; 41:610-622. [PMID: 30827932 PMCID: PMC6444073 DOI: 10.1016/j.ebiom.2019.02.027] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Revised: 02/07/2019] [Accepted: 02/13/2019] [Indexed: 01/17/2023] Open
Abstract
Background We recently demonstrated the increased abundance of anti-trophoblast antibodies (ATAB) in sera of patients with unexplained recurrent miscarriages (uRM). Further, the ATAB-positive sera bound to JEG-3 human choriocarcinoma cells in vitro, resulting in decreased productions of β-human chorionic gonadotropin (β-hCG) and progesterone in these cells. However, the specific antigenic epitopes of ATAB have remained unknown. Therefore, it was the aim of this study to determine specific targets of ATAB in uRM patients. Methods Potential targets of ATAB were analyzed by 2-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry, and thereby identifying α-Enolase (ENO1). ATAB targeting of ENO1 was further confirmed in a competitive binding assay. Levels of anti-ENO1 antibodies as well as β-hCG and progesterone were quantified with enzyme-linked immunosorbent assay (ELISA). Additionally, expression of ENO1 was analyzed in first trimester placentas by immunohistochemistry and immunofluorescence analysis. Findings We here identified ENO1 as a prominent target of ATAB. Serum levels of anti-ENO1 antibodies were increased in ATAB-positive compared to ATAB-negative patients. Further, increased expression of ENO1 and its co-expression with β-arrestin was found in the extra villous trophoblasts of uRM patients in first trimester placentas. In vitro, anti-ENO1 antibodies decreased the secretion of β-hCG and progesterone in JEG-3 and primary human villous trophoblast cells. Interpretation Serum anti-ENO1 antibodies might be an autoimmune biomarker for uRM. Targeting the formation of anti-ENO1 antibodies or inhibition of ENO1 expression could potentially represent therapeutic strategies for these patients. Fund All authors declare no conflict of interest. Yao Ye was supported by the China Scholarship Council. Hellen Ishikawa-Ankerhold and Christian Schulz were supported by the SFB914, projects Z01 and A10. None of the rest authors has any conflict of interest to declare.
Collapse
Affiliation(s)
- Yao Ye
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| | - Christina Kuhn
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| | - Miwako Kösters
- Laboratory for Functional Genome Analysis LAFUGA, Gene Center, Ludwig-Maximilians -University, 81377 Munich, Germany
| | - Georg J Arnold
- Laboratory for Functional Genome Analysis LAFUGA, Gene Center, Ludwig-Maximilians -University, 81377 Munich, Germany
| | - Hellen Ishikawa-Ankerhold
- Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians -University, 81377 Munich, Germany
| | - Christian Schulz
- Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians -University, 81377 Munich, Germany
| | - Nina Rogenhofer
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| | - Christian J Thaler
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| | - Sven Mahner
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| | - Thomas Fröhlich
- Laboratory for Functional Genome Analysis LAFUGA, Gene Center, Ludwig-Maximilians -University, 81377 Munich, Germany
| | - Udo Jeschke
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany.
| | - Viktoria von Schönfeldt
- Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany
| |
Collapse
|
16
|
Affiliation(s)
- Corinna Mann
- Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig Maximilians Universität München, Campus Innenstadt, Maistrasse 11, D-80337, München, Deutschland.
| | - Sven Mahner
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, München, Deutschland
| | - Christian J Thaler
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, München, Deutschland
| |
Collapse
|
17
|
Mischitz DS, Rogenhofer N, Mann C, Schönfeldt V, Mahner S, Thaler CJ. Oxytocin-Antagonisten bei rezidivierendem Implantationsversagen. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1670984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- DS Mischitz
- LMU München, Gynäkologie und Geburtshilfe, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - N Rogenhofer
- LMU München, Gynäkologie und Geburtshilfe, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - C Mann
- LMU München, Gynäkologie und Geburtshilfe, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - V Schönfeldt
- LMU München, Gynäkologie und Geburtshilfe, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - S Mahner
- LMU München, Gynäkologie und Geburtshilfe, München, Deutschland
| | - CJ Thaler
- LMU München, Gynäkologie und Geburtshilfe, Hormon- und Kinderwunschzentrum, München, Deutschland
| |
Collapse
|
18
|
Rogenhofer N, Mischitz D, Mann C, Schönfeldt V, Jeschke U, Mahner S, Thaler CJ. Saisonale Effekte auf AMH-Konzentration und kontrollierte ovarielle Hyperstimulationstherapie im Rahmen von IVF/ICSI. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- N Rogenhofer
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - D Mischitz
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - C Mann
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - V Schönfeldt
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - U Jeschke
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - S Mahner
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - CJ Thaler
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| |
Collapse
|
19
|
Mann C, Erdelkamp R, Rogenhofer N, Mischitz D, Schönfeldt V, Mahner S, Mayr D, Thaler CJ. Kein Hinweis auf Häufung endometrialer CD138+Plasmazellen bei rezidivierendem Implantationsversagen oder Spontanaborten. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1670982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- C Mann
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - R Erdelkamp
- Pathologisches Institut der LMU München, München, Deutschland
| | - N Rogenhofer
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - D Mischitz
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - V Schönfeldt
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, Hormon- und Kinderwunschzentrum, München, Deutschland
| | - S Mahner
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, München, Deutschland
| | - D Mayr
- Pathologisches Institut der LMU München, München, Deutschland
| | - CJ Thaler
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Klinikum der Universität München, Hormon- und Kinderwunschzentrum, München, Deutschland
| |
Collapse
|
20
|
Rogenhofer N, Mischitz D, Mann C, Schönfeldt V, Jeschke U, Mahner S, Thaler CJ. Body Mass Indix (BMI) und Outcome der Assistierten Reproduktionsmedizinischen Therapie (ART). Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- N Rogenhofer
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - D Mischitz
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - C Mann
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - V Schönfeldt
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - U Jeschke
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - S Mahner
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - CJ Thaler
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| |
Collapse
|
21
|
Rogenhofer N, Mischitz D, Schönfeldt V, Jeschke U, Mahner S, Thaler CJ. Saisonale Korrelation der Serumkonzentration von Folsäure und Vitamin B12 (B12) mit Cholecalciferol (D3) bei IVF/ICSI-Patientinnen. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- N Rogenhofer
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - D Mischitz
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - V Schönfeldt
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - U Jeschke
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - S Mahner
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| | - CJ Thaler
- Klinikum der Ludwig-Maximilians-Universität München, Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München, Deutschland
| |
Collapse
|
22
|
Rogenhofer N, Ott J, Pilatz A, Wolf J, Thaler CJ, Windischbauer L, Schagdarsurengin U, Steger K, von Schönfeldt V. Unexplained recurrent miscarriages are associated with an aberrant sperm protamine mRNA content. Hum Reprod 2018; 32:1574-1582. [PMID: 28854581 DOI: 10.1093/humrep/dex224] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2016] [Accepted: 05/28/2017] [Indexed: 11/14/2022] Open
Abstract
STUDY QUESTION Are unexplained recurrent miscarriages associated with abnormal protamine-1 and protamine-2 mRNA levels in spermatozoa? SUMMARY ANSWER Both protamine-1 and protamine-2 mRNA levels as well as the protamine-1 to protamine-2 mRNA ratio in spermatozoa from men whose female partners experienced two or more consecutive miscarriages were significantly different compared to those from both healthy control men and subfertile couples undergoing IVF/ICSI. WHAT IS KNOWN ALREADY Aberrant sperm protamine ratios are known to be associated with male-factor infertility. Data from this study suggest that the protamine mRNA ratio may additionally affect early embryo development. STUDY DESIGN, SIZE, DURATION The study population was recruited from men whose female partners presented with two or more consecutive unexplained miscarriages in a consultation for recurrent pregnancy loss between 2014 and 2016. At the research laboratory of the Urological Clinic of the University Giessen, spermatozoa from cases and controls were subjected to reverse transcription quantitative PCR (RTqPCR) using specific primer pairs for protamine-1 and protamine-2. PARTICIPANTS/MATERIALS, SETTING, METHODS Protamine-1 and protamine-2 mRNA levels were analysed in semen samples from 25 men whose female partners experienced at least two consecutive idiopathic miscarriages before the 20th week of gestation. The couples were recruited during consultation at the Fertility Center of the LMU Munich, Germany, and at the Clinical Division of Gynecologic Endocrinology and Reproductive Medicine of the Medical University of Vienna, Austria. Results were compared with those from 32 healthy donors (WHO, 2010) recruited at the Department of Urology, Pediatric Urology and Andrology, Giessen, Germany, and 107 men whose partners participated in an IVF/ICSI program at the Fertility Center of the LMU Munich, Germany. MAIN RESULTS AND THE ROLE OF CHANCE Protamine-1 and protamine-2 mRNA levels as well as the protamine mRNA ratio and all routine semen parameters revealed significant differences between recurrent miscarriage couples and healthy volunteers (P < 0.01). When comparing recurrent miscarriage couples with couples undergoing IVF/ICSI, Ct-values of protamine-1 and protamine-2 mRNAs were significantly higher and the protamine mRNA ratio was significantly lower in RM couples (P < 0.01). When comparing protamine mRNA levels and the protamine mRNA ratio with routine semen parameters, a significant negative correlation was evident between progressive motility and the protamine-2 mRNA level (P = 0.015), as well as between non-progressive motility and the protamine mRNA ratio (P = 0.023). LIMITATIONS REASONS FOR CAUTION Although our data demonstrate significant abnormalities in RM, larger sample sizes will be needed to confirm our results. Larger sample sizes should also balance the fact that we had to focus mainly on median protamine mRNA levels. Finally, men in the healthy control group were younger in age than those in the case group, which might have introduced some bias, at least concerning the classic semen parameters. Moreover, only protamine mRNA instead of protein levels could be measured. WIDER IMPLICATIONS OF THE FINDINGS Although the exact mechanism remains to be elucidated, our data suggest that protamine mRNA levels in spermatozoa are not only important for successful fertilization, but also for proper development of the early embryo. STUDY FUNDING/COMPETING INTEREST(S) Grant from the University Clinic Giessen and Marburg (UKGM 29/2015GI). There are no competing interests. TRIAL REGISTRATION NUMBER N/A.
Collapse
Affiliation(s)
- Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Ludwig-Maximilians-University (LMU) Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
| | - Johannes Ott
- Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
| | - Adrian Pilatz
- Department of Urology, Pediatric Urology and Andrology, Justus Liebig University Giessen, Schubertstraße 81, 35392 Giessen, Germany
| | - Julia Wolf
- Department of Urology, Pediatric Urology and Andrology, Justus Liebig University Giessen, Schubertstraße 81, 35392 Giessen, Germany
| | - Christian J Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Ludwig-Maximilians-University (LMU) Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
| | - Lisa Windischbauer
- Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
| | - Undraga Schagdarsurengin
- Department of Urology, Pediatric Urology and Andrology, Justus Liebig University Giessen, Schubertstraße 81, 35392 Giessen, Germany
| | - Klaus Steger
- Department of Urology, Pediatric Urology and Andrology, Justus Liebig University Giessen, Schubertstraße 81, 35392 Giessen, Germany
| | - Viktoria von Schönfeldt
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Ludwig-Maximilians-University (LMU) Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
| |
Collapse
|
23
|
Beier HM, Bujard M, Diedrich K, Dreier H, Frister H, Kentenich H, Kreß H, Krüssel JS, Ludwig AK, Schumann E, Strowitzki T, Taupitz J, Thaler CJ, Thorn P, Wiesemann C, Zenner HP. Ein Fortpflanzungsmedizingesetz für Deutschland. Gynäkologische Endokrinologie 2018. [DOI: 10.1007/s10304-017-0173-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Beier HM, Bujard M, Diedrich K, Dreier H, Frister H, Kentenich H, Kreß H, Krüssel JS, Ludwig AK, Schumann E, Strowitzki T, Taupitz J, Thaler CJ, Thorn P, Wiesemann C, Zenner HP. Ein Fortpflanzungsmedizingesetz für Deutschland. Ethik Med 2018. [DOI: 10.1007/s00481-017-0467-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Hulde N, Rogenhofer N, Brettner F, Eckert NC, Götzfried I, Nguyen T, Pagel JI, Kammerer T, Hofmann-Kiefer KF, Schelling G, Dendorfer A, Rehm M, Thaler CJ. The CYCLOCALYX study: Ovulatory cycle affects circulating compartments of the endothelial glycocalyx in blood. Am J Reprod Immunol 2017; 79. [DOI: 10.1111/aji.12767] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Accepted: 08/31/2017] [Indexed: 12/24/2022] Open
Affiliation(s)
- Nikolai Hulde
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine; Department of Gynecology and Obstetrics; Ludwig-Maximilians University; Munich Germany
| | - Florian Brettner
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Nicole C. Eckert
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Isabella Götzfried
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Thu Nguyen
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Judith-I. Pagel
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Tobias Kammerer
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | | | - Gustav Schelling
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Andreas Dendorfer
- Walter Brendel Zentrum; Ludwig-Maximilians University; Munich Germany
| | - Markus Rehm
- Department of Anesthesiology; Ludwig-Maximilians University; Munich Germany
| | - Christian J. Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine; Department of Gynecology and Obstetrics; Ludwig-Maximilians University; Munich Germany
| |
Collapse
|
26
|
Ye Y, Vattai A, Zhang X, Zhu J, Thaler CJ, Mahner S, Jeschke U, von Schönfeldt V. Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases. Int J Mol Sci 2017; 18:ijms18081651. [PMID: 28758928 PMCID: PMC5578041 DOI: 10.3390/ijms18081651] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Revised: 07/24/2017] [Accepted: 07/27/2017] [Indexed: 01/13/2023] Open
Abstract
Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). In human placentas, PAI-1 is expressed in extravillous interstitial trophoblasts and vascular trophoblasts. During implantation and placentation, PAI-1 is responsible for inhibiting extra cellular matrix (ECM) degradation, thereby causing an inhibition of trophoblasts invasion. In the present study, we have reviewed the literature of various reproductive diseases where PAI-1 plays a role. PAI-1 levels are increased in patients with recurrent pregnancy losses (RPL), preeclampsia, intrauterine growth restriction (IUGR), gestational diabetes mellitus (GDM) in the previous pregnancy, endometriosis and polycystic ovary syndrome (PCOS). In general, an increased expression of PAI-1 in the blood is associated with an increased risk for infertility and a worse pregnancy outcome. GDM and PCOS are related to the genetic role of the 4G/5G polymorphism of PAI-1. This review provides an overview of the current knowledge of the role of PAI-1 in reproductive diseases. PAI-1 represents a promising monitoring biomarker for reproductive diseases and may be a treatment target in the near future.
Collapse
Affiliation(s)
- Yao Ye
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Aurelia Vattai
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Xi Zhang
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Junyan Zhu
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Christian J Thaler
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Sven Mahner
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Udo Jeschke
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| | - Viktoria von Schönfeldt
- Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Großhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany.
| |
Collapse
|
27
|
Mann C, Rogenhofer N, Mahner S, Thaler CJ. [The renaissance of hormonal therapy]. MMW Fortschr Med 2017; 159:39-42. [PMID: 28550548 DOI: 10.1007/s15006-017-9705-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
- Corinna Mann
- Hormon- und Kinderwunschzentrums, Ludwig-Maximilians-Universität, Maistraße 11, D-80337, München, Deutschland.
| | - Nina Rogenhofer
- Hormon- und Kinderwunschzentrums, Ludwig-Maximilians-Universität, Maistraße 11, D-80337, München, Deutschland
| | - Sven Mahner
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Ludwig-Maximilians-Universität, München, Deutschland
| | - Christian J Thaler
- Hormon- und Kinderwunschzentrums, Ludwig-Maximilians-Universität, Maistraße 11, D-80337, München, Deutschland
| |
Collapse
|
28
|
Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ. Möglicher Benefit einer niedermolekularen Heparinisierung in der Schwangerschaft bei habituellen Aborten und M2/Annexin-A5 (ANXA-5) Trägerschaft: post-hoc Analyse der EThiG-II-Studie. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
29
|
Rogenhofer N, Ott J, Schönfeldt VV, Pilatz A, Wolf J, Windischbauer L, Mittenzwei S, Mahner S, Thaler CJ, Steger K. Verminderte Protamin-mRNA Ratio humaner Spermatozoen scheint mit rezidivierenden Aborten assoziiert. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
30
|
Rogenhofer N, Mittenzwei S, Gluderer J, Schönfeldt VV, Mahner S, Thaler CJ. Assoziation von Cholecalciferol (D3) Serumkonzentrationen mit Rahmenaspekten der Assistierten Reproduktionsmedizinischen Therapie (ART). Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
31
|
Rogenhofer N, Nienhaber L, Mittenzwei S, Bogdanova N, Markoff A, Mahner S, Thaler CJ. Paternale M2/Annexin-A5 Trägerschaft als Risikofaktor für IUGR, Präklampsie und Frühgeburtlichkeit. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
32
|
Ye Y, Vogel M, Burger P, Rogenhofer N, Mahner S, Jeschke U, Thaler CJ, Schönfeldt VV. Prurified anti-trophoblast antibodies (ATAB) suppress the secretion of human Chorionic Gonadotropin (hCG) and stimulate that of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in vitro. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
33
|
Eggersmann TK, Schuster V, Eifert S, Kolben TM, Ueberfuhr P, Zugenmaier B, Kublickiene K, Reichart B, Hagl C, Pichlmaier M, Mahner S, Guethoff S, Thaler CJ. Ascending aortic disease is associated with earlier menopause and shorter reproductive life span. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
34
|
Sela L, Rogenhofer N, Mittenzwei S, Mahner S, Thaler CJ, Schönfeldt VV. Higher pregnancy rate of embryos with synchronous transition from the 2-cell to the 4-cell stage independently of the GnRH analogue used for controlled ovarian stimulation. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
35
|
Franz M, Marschalek J, Ott J, Pavlik R, Watrelot A, Thaler CJ. A comparison of transabdominal versus transvaginal laparoscopic ovarian drilling for polycystic ovary syndrome. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
36
|
Rogenhofer N, Gluderer J, Crispin A, Bond G, Zeisler H, Thaler CJ. Anti-Trophoblast Antikörper (ATAk) sind spezifisch für idiopathische Spontanaborte und nicht mit Antikörpern gegen allogenes HLA assoziiert. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
37
|
Müller-Stoy G, Pavlik R, Alba Alejandre I, Kästner R, Gülberg V, Mahner S, Thaler CJ. Schwere toxische Leberschädigung nach ICSI und nachfolgender Schwangerschaft. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
38
|
von Schönfeldt V, Rogenhofer N, Ruf K, Thaler CJ, Jeschke U. Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitro. J Reprod Immunol 2016; 117:52-6. [DOI: 10.1016/j.jri.2016.07.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 07/12/2016] [Accepted: 07/17/2016] [Indexed: 11/17/2022]
|
39
|
Schuster V, Eggersmann TK, Eifert S, Ueberfuhr P, Zugenmaier B, Kolben TM, Thaler CJ, Kublickiene K, Rieger A, Reichart B, Hagl C, Pichlmaier MA, Guethoff S. Ascending Aortic Disease is Associated with Earlier Menopause and Shorter Reproductive Life Span. J Womens Health (Larchmt) 2016; 25:912-9. [DOI: 10.1089/jwh.2015.5559] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Affiliation(s)
- Verena Schuster
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
- Department of Anaesthesiology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Tanja K. Eggersmann
- Department of Obstetrics and Gynaecology, Ludwig-Maximilians-Universität München, Munich, Germany
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Sandra Eifert
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Peter Ueberfuhr
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Brita Zugenmaier
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Theresa M. Kolben
- Department of Obstetrics and Gynaecology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Christian J. Thaler
- Department of Obstetrics and Gynaecology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Karolina Kublickiene
- Department of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University, Stockholm, Sweden
| | - Anna Rieger
- Institute for Medical Information Sciences, Biometry and Epidemiology (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
| | - Bruno Reichart
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Christian Hagl
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
| | | | - Sonja Guethoff
- Department of Cardiac Surgery, Ludwig-Maximilians-Universität München, Munich, Germany
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
| |
Collapse
|
40
|
Abstract
This study presents sample size considerations derived from the Efficacy of Thromboprophylaxis as an Intervention during Gravidity (EThIGII) trial (ClinicalTrials.gov: NCT00400387) to address the question of low-molecular-weight heparin (LMWH) treatment in women with recurrent pregnancy loss (RPL) depending on the M2/ANXA5 haplotype. To evaluate the possible influence of such treatment on miscarriage rates of trial participants, a post hoc analysis of ANXA5 promoter genotypes in the light of M2/ANXA5 ( RPRGL3) distribution was performed using logistic models. DNA for genotyping was available from 129 LMWH and 95 control patients, 44 (19.6%) of whom were M2/ANXA5 carriers. Miscarriages occurred in 1 (4.0%) of 25 M2/ANXA5 carriers from the LMWH group compared to 4 (21.1%) of 19 in the control group, resulting in an odds ratio (95% confidence interval) for miscarriage of 0.16 (0.016-1.5) for women treated with LMWH. In noncarriers, miscarriage rates were 6 (5.8%) of 104 versus 7 (9.2%) of 76 for the LMWH and the control groups, respectively, corresponding to an odds ratio for miscarriage of 0.60 (0.19-1.9). The apparent beneficial effects of miscarriage rate reduction in M2/ANXA5 carriers with RPL concur with biological considerations about improvement in reduced ANXA5 function through LMWH treatment in an adequate murine model. The data obtained were instrumental to design proper assessment of the existence and magnitude of this effect.
Collapse
Affiliation(s)
- Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany
| | - Arseni Markoff
- Insititute of Human Genetics, UKM and WWU Muenster, Muenster, Germany
| | - Annett Wagner
- Center for Human Genetics and Laboratory Diagnostics, Dr Klein, Dr Rost and Colleagues, Martinsried, Germany
| | - Hanns-Georg Klein
- Center for Human Genetics and Laboratory Diagnostics, Dr Klein, Dr Rost and Colleagues, Martinsried, Germany
| | - David Petroff
- Clinical Trial Centre, University of Leipzig, Leipzig, Germany
| | | | - Christian J. Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany
| | | |
Collapse
|
41
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, von Schönfeldt V. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in. J Reprod Immunol 2016. [DOI: 10.1016/j.jri.2016.04.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, von Schönfeldt V. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in. J Reprod Immunol 2016. [DOI: 10.1016/j.jri.2016.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Heublein S, Hecht S, Nick V, Thaler CJ, Mahner S, Jeschke U, Pavlik R. Regulation der ovariellen Steroidbiosynthese über das Stresshormon CRH am Modell humaner kultivierter Granulosazellen. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1580641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
44
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, Schönfeldt VV. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in vitro. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1580647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
45
|
Neusser M, Rogenhofer N, Dürl S, Ochsenkühn R, Trottmann M, Jurinovic V, Steinlein O, von Schönfeldt V, Müller S, Thaler CJ. Increased chromosome 16 disomy rates in human spermatozoa and recurrent spontaneous abortions. Fertil Steril 2015; 104:1130-7.e1-10. [PMID: 26318886 DOI: 10.1016/j.fertnstert.2015.07.1160] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2014] [Revised: 07/25/2015] [Accepted: 07/27/2015] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To investigate if unexplained recurrent spontaneous abortions (RSA) are associated with increased rates of aneuploidy in spermatozoa of RSA partners ("RSA-men"). DESIGN Case-control study. SETTING Academic research center. PATIENT(S) Patients enrolled at the Hormone and Fertility Center and controls at the Department of Urology (LMU-Munich). INTERVENTION(S) Sperm samples of 11 partners of unexplained RSA cases evaluated for elevated diploidy and disomy levels of chromosomes 1-22, X, and Y by multicolor sperm fluorescence in situ hybridization (FISH). MAIN OUTCOME MEASURE(S) Aneuploidy rates obtained in RSA-men compared with controls from the literature and internally; an increase of the aneuploidy rate was considered statistically significant, when it differed ≥ 2 standard deviations from the mean baseline level in controls. RESULT(S) Our sperm FISH data on RSA men showed increased disomy rates for at least three chromosomes in more than 60% of patients but no statistically significant increase of the overall mean sperm disomy or diploidy rate. In particular, meiotic errors involving chromosome 16 contributed to increased sperm disomy in more than 60% of our patients. CONCLUSION(S) These data suggest that among paternal meiotic errors nondisjunction of chromosome 16 might have similar relative influence on fetal aneuploidy compared with maternal chromosome 16 disomy.
Collapse
Affiliation(s)
- Michaela Neusser
- Institute of Human Genetics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
| | - Nina Rogenhofer
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Ludwig Maximilian University of Munich, Munich, Germany
| | - Stephanie Dürl
- Institute of Human Genetics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
| | | | - Matthias Trottmann
- Department of Urology, Ludwig Maximilian University of Munich, Munich, Germany
| | - Vindi Jurinovic
- Institute for Medical Informatics, Biometry and Epidemiology, Ludwig Maximilian University of Munich, Munich, Germany
| | - Ortrud Steinlein
- Institute of Human Genetics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
| | - Viktoria von Schönfeldt
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Ludwig Maximilian University of Munich, Munich, Germany
| | - Stefan Müller
- Institute of Human Genetics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
| | - Christian J Thaler
- Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Ludwig Maximilian University of Munich, Munich, Germany
| |
Collapse
|
46
|
Thaler CJ. Folate Metabolism and Human Reproduction. Geburtshilfe Frauenheilkd 2014; 74:845-851. [PMID: 25278626 DOI: 10.1055/s-0034-1383058] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 08/13/2014] [Accepted: 08/14/2014] [Indexed: 10/24/2022] Open
Abstract
Folate metabolism affects ovarian function, implantation, embryogenesis and the entire process of pregnancy. In addition to its well-established effect on the incidence of neural tube defects, associations have been found between reduced folic acid levels and increased homocysteine concentrations on the one hand, and recurrent spontaneous abortions and other complications of pregnancy on the other. In infertility patients undergoing IVF/ICSI treatment, a clear correlation was found between plasma folate concentrations and the incidence of dichorionic twin pregnancies. In patients supplemented with 0.4 mg/d folic acid undergoing ovarian hyperstimulation and oocyte pick-up, carriers of the MTHFR 677T mutation were found to have lower serum estradiol concentrations at ovulation and fewer oocytes could be retrieved from them. It appears that these negative effects can be compensated for in full by increasing the daily dose of folic acid to at least 0.8 mg. In carriers of the MTHFR 677TT genotype who receive appropriate supplementation, AMH concentrations were found to be significantly increased, which could indicate a compensatory mechanism. AMH concentrations in homozygous carriers of the MTHFR 677TT genotype could even be overestimated, as almost 20 % fewer oocytes are retrieved from these patients per AMH unit compared to MTHFR 677CC wild-type individuals.
Collapse
Affiliation(s)
- C J Thaler
- Department and Outpatient Clinic for Gynaecology and Obstetrics, Hospital of the Ludwig Maximilian University of Munich, Großhadern Campus, Hormone & Fertility Centre Großhadern, Munich ; Department and Outpatient Clinic for Gynaecology and Obstetrics, Hospital of the Ludwig Maximilian University of Munich, City Centre Campus, Hormone & Fertility Centre City Centre, Munich
| |
Collapse
|
47
|
Rogenhofer N, Mittenzwei S, Schönfeldt VV, Gluderer J, Thaler CJ. Cholecalciferol (D3) Serumkonzentrationen bei IVF/ICSI-Patientinnen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
48
|
Sela L, Mittenzwei S, Rogenhofer N, Friese K, Thaler CJ, Schönfeldt VV. Nutzen der Time-Lapse Technologie zur Identifizierung von befruchteten Eizellen mit einem zeitlich diskordant auftretenden 3. Vorkern (Pronukleus). Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1387971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
49
|
Schönfeldt VV, Rogenhofer N, Friese K, Thaler CJ, Jeschke U. Anti-Trophoblast-Antikörper (ATAK) im Serum von Patientinnen mit rezidivierenden Spontanaborten (RSA) sind Antikörper gegen Prostaglandin-E-Rezeptor-3 (EP3). Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1387986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
50
|
Hecht S, Heublein S, Pavlik R, Noss U, Vrekoussis T, Jeschke U, Thaler CJ. Auswirkungen des Folatantagonisten Methotrexat auf Apoptose und Steroidmetabolismus humaner primärer Granulosazellen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|